Demostrar las medidas de terapia respiratoria para la aplicación temprana y tardía de surfactante pulmonar en neonatos
No hay miniatura disponible
Fecha
2014
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Tecnología Médica
Resumen
El uso de surfactante pulmonar es muy usado como tratamiento base para poder mejorar el pulmón prematuro que tiene un neonato, En los neonatos menores de 35 semanas de edad gestacional, se puede producir un estadio morboso caracterizado por ausencia o aun no total formación del fosfolípidos o surfactante pulmonar este líquido esencial es producido por las células alveolares Tipo II, que cubre los alveolos y pequeños bronquiolos.
Se llevara cabo un trabajo con el cual usaremos diferente medidas para la aplicación del surfactante observando sus beneficios y el riesgo que puede ser si no tomamos las debidas precauciones.
Con los avances de la tecnología se ha logrado sintetizar estos fosfolípidos, que ha mejorado significativamente la sobrevivencia del neonato menor de 35 semanas, entre más temprano es aplicado el surfactante el pronóstico del paciente mejora.
Pero si tardíamente el surfactante es aplicado también debemos de saber cuál es la probabilidad de mortalidad del neonato y mejorar su estatus crítico que se encuentra.
Es importante mantener un ambiente térmico ideal ya que estos pacientes no regulan su temperatura corporal debido a su prematurez, se realiza un control de signos vitales, gasométricos, radiografías de tórax seriados y dependiendo de la patología del paciente se podría administrar surfactante, que existe en el mercado. Posteriormente se instalara al paciente en Ventilación Mecánica Invasiva o no Invasiva considerando los riesgos que la utilización de surfactante puede provocar.
The use of pulmonary surfactant is used as a base treatment to improve the preterm lung having a newborn , in infants less than 35 weeks gestational age, can produce a morbid stage characterized by absence or even not complete formation of phospholipids or this essential liquid lung surfactant is produced by type II alveolar cells , covering the alveoli and small bronchioles. They carry out a job that will use different measures for the application of surfactant observing its benefits and risks can be if we do not take proper precautions . With advances in technology it has been possible to synthesize these phospholipids, which has significantly improved the survival of the infant less than 35 weeks , the earlier applied surfactant improves the prognosis of the patient . But if belatedly surfactant is also implemented we must know the probability of infant mortality and improve their status which is critical . It is important to maintain an ideal thermal environment because these patients do not regulate their body temperature because of their prematurity , monitoring of vital signs, blood gases , chest x- serial chest and depending on the condition of the patient may be given surfactant that exists is made market . The patient was then installed in Invasive Mechanical Ventilation Invasive or not considering the risks that the use of surfactant may cause.
The use of pulmonary surfactant is used as a base treatment to improve the preterm lung having a newborn , in infants less than 35 weeks gestational age, can produce a morbid stage characterized by absence or even not complete formation of phospholipids or this essential liquid lung surfactant is produced by type II alveolar cells , covering the alveoli and small bronchioles. They carry out a job that will use different measures for the application of surfactant observing its benefits and risks can be if we do not take proper precautions . With advances in technology it has been possible to synthesize these phospholipids, which has significantly improved the survival of the infant less than 35 weeks , the earlier applied surfactant improves the prognosis of the patient . But if belatedly surfactant is also implemented we must know the probability of infant mortality and improve their status which is critical . It is important to maintain an ideal thermal environment because these patients do not regulate their body temperature because of their prematurity , monitoring of vital signs, blood gases , chest x- serial chest and depending on the condition of the patient may be given surfactant that exists is made market . The patient was then installed in Invasive Mechanical Ventilation Invasive or not considering the risks that the use of surfactant may cause.
Descripción
PDF
Palabras clave
RECIEN NACIDO, SURFACTANTES PULMONARES, UNIDA DE CUIDADOS INTENSIVO NEONATAL, HOSPITAL DEL NIÑO FRANCISCO DE ICAZA BUSTAMANTE, CANTON GUAYAQUIL, ECUADOR, REPIRACION ARTIFICIAL